Redcare Pharmacy lifts FY 2026 revenue growth outlook to 16%-18%
Bitget2026/09/28 11:49- Redcare Pharmacy lifted full-year 2026 revenue guidance for a second time, citing sustained prescription-drug momentum in Germany.
- Total revenue growth now seen at 16% to 18%, up from 15% to 17%; non-Rx growth maintained at 10% to 12%.
- Germany Rx revenue forecast raised to EUR 730-760 million, implying 45% to 51% growth versus EUR 680-720 million previously.
- Adjusted EBITDA margin outlook kept at 2.5% to 3.0%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The British Pound rallies on a UK growth upgrade and gives more than half back
Only twice in history! S&P 500 equal-weight index is expected to record seven consecutive weeks of decline this week
The S&P 500 Equal Weight Index is expected to fall for a seventh consecutive week. If this downward trend continues through Friday, it will mark only the third time in history that the index has experienced seven straight weeks of decline.
Trump “bites” Powell, demanding his resignation from the Federal Reserve Board, citing severe cost overruns in headquarters renovation.
U.S. President Trump on Wednesday called for former Federal Reserve Chairman Powell to resign from his position as a Fed governor, following an inspector general report on the Federal Reserve headquarters renovation project, which highlighted a series of management issues that led to significant cost overruns.
Crypto prices
More
